Clinical Trial Update: The Effect of Spironolactone on Acute Kidney Injury in Patients Undergoing Coronary Angiography [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the effect of spironolactone on acute kidney injury in patients undergoing coronary angiography has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy
• Ischemic Heart Disease
• Kidney Injury

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: Alhasan Mujtaba Abdul-Wahid | Conditions: Acute Kidney Injury, IHD | Phase 2 | Status: COMPLETED